O, D., Y, K., S, C., N, R., Z, O., S, K., . . . M, I. (2025). Systemic secukinumab treatment in patients with ankylosing spondylitis: The relationship between systemic and tear proinflammatory cytokines and ocular surface findings-a pilot study. Clinical rheumatology, 44(7), 2775. https://doi.org/10.1007/s10067-025-07492-y
Chicago Style (17th ed.) CitationO, Dikmetas, et al. "Systemic Secukinumab Treatment in Patients with Ankylosing Spondylitis: The Relationship Between Systemic and Tear Proinflammatory Cytokines and Ocular Surface Findings-a Pilot Study." Clinical Rheumatology 44, no. 7 (2025): 2775. https://doi.org/10.1007/s10067-025-07492-y.
MLA (9th ed.) CitationO, Dikmetas, et al. "Systemic Secukinumab Treatment in Patients with Ankylosing Spondylitis: The Relationship Between Systemic and Tear Proinflammatory Cytokines and Ocular Surface Findings-a Pilot Study." Clinical Rheumatology, vol. 44, no. 7, 2025, p. 2775, https://doi.org/10.1007/s10067-025-07492-y.